Clinical Trial Detail

NCT ID NCT03282344
Title A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Memorial Sloan Kettering Cancer Center
Indications

malignant fibroxanthoma

osteosarcoma

pleomorphic liposarcoma

angiosarcoma

chondrosarcoma

leiomyosarcoma

Therapies

NKTR-214 + Nivolumab

Age Groups: adult senior

No variant requirements are available.